Library

ADB-INACA

ADB-INACA is an indazole-3-carboxamide frequently detected as a precursor or minor component alongside potent synthetic cannabinoids in seized products; real-world harms often reflect co-formulation with more active compounds rather than pure ADB-INACA effects. As a suspected precursor to compounds like ADB-BUTINACA, overall potency is expected to be low, though pharmacological data remain limited. Treat unknown powders and sprayed materials as if they contain nanomolar CB1 agonists; never eyeball doses, use a milligram scale or volumetric solutions, start at sub-milligram smoked or low-milligram oral doses, and wait through the full peak before redosing. Plant matter and papers can have uneven application creating dangerous hotspots; thorough homogenization and dilute solutions reduce per-puff variability. Acute risks for synthetic cannabinoids include tachycardia, severe anxiety or panic, agitation, nausea, confusion, transient psychosis, seizures, and rare hyperthermia, rhabdomyolysis, acute kidney injury, and cardiotoxicity; polydrug use amplifies these dangers.